🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TPO receptor agonists in pregnancy #ASH24

The beauty and complexity of ITP in a slide 😍 Courtesy of Dr. Michele Lambert #ASH24 #ClassicalHematology

HIT is a complex disease disease. Insightful peaks on the management of HIT provided at #ASH24 👇

Oral HRT increases venous thrombotic risk (VTE). Tibolone increases arterial but not VTE risk. Topical HRT showed no increase in either. Huge prospective Swedish study: 919,614 women of whom 77,512 started HRT. tinyurl.com/85jxatux #HRT

#ASH24 #mmsm ASH Neurological manifestations of MGUS

Fascinating study from administrative data showing 20% lower risk of #VTE with GLP-1 receptor agonist use in diabetes in a large population sample. Association was similar even in people with normal BMI. #ASH24

ASH Late Breaking Abstract: Should patients receive extended duration anticoagulation with reduced or full dose DOAC for the secondary prevention of recurrent VTE - The RENOVE RCT presented by Francis Couturaud Reduced dose DOAC was not non inferior to full dose ((5-year

Extended-dose DOAC vs full-dose DOAC #Renove RCT #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congrats to Francis Couturaud & INNOVTE

The ASH #TreatingFairly initiative is a new pilot program focused on delivering equitable care for all patients. Please share your ideas and topics for the Treating Fairly Recommendations List using the survey below. hematology.questionpro.com/a/TakeSurvey?t…

Doctors need to do more to help women - note #irondeficiency is the most common disability bmj.com/content/387/bm…

Until now, (non-approved) emicizumab use in acquired hemophilia A was all about reduction in bleeds and improved convenience for patients and medical staff. Now the German group showed at #ASH2024 that it results in improved survival. Not randomised but impressive.

Congenital #TTP is a rare disease caused by ADAMTS13 deficiency, often remaining undiagnosed until adulthood. A study of 9 pediatric patients treated with recombinant ADAMTS13 showed improved platelet counts, reduced lactate dehydrogenase levels, and enhanced quality of life with

📢 #Top10 #RPTH2024 – Day 2 🏅 #9 State Of The Art Review: Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use 🔑 Safe & improves QOL, but barriers like period poverty, stigma, & misinformation limit access! Michelle Sholzberg

Huge congrats Shiphra Ginsburg on this amazing and well-deserved honour! Department of Medicine University of Toronto

Congratulations amazing Dr Sarah Ge ⭐️

How do we distinguish DIC vs. cirrhotic coagulopathy? A new ISTH SSC communication reviewed the overlap and distinctions between disseminated intravascular coagulation (DIC) and cirrhotic coagulopathy in patients with cirrhosis. #DIC #platelet #cirrhosis

Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations - The Lancet Haematology thelancet.com/journals/lanha…

What makes von Willebrand Disease so tricky to diagnose? On the latest #HemeTalks pocast, Dr. Jill Johnsen and Dr. Michelle Sholzberg explore the most common inherited bleeding disorder. 🎧: ow.ly/SNz950VSNaw #ASHEducation #BleedingDisroder #VWD #Hematology

Dr. Claudia dos Santos, a physician-scientist at St. Michael's, spoke to The Globe and Mail about a new test that can quickly & accurately predict #sepsis risk. Dr. dos Santos and a team of researchers developed the test that requires just a pinprick of blood. theglobeandmail.com/canada/article…

Congrats to our amazing hematology graduates this year! Such a privilege to work with you all. Temerty Medicine